Pronalyse Unveils Insightful Metabolite Identification Services of Biopharmaceuticals

Creative Proteomics Has Optimized Pre-treatments and Assays for Different Types of Vitamins

Cardio Diagnostics Announces Issuance of U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular Disease

Springer Nature Joins PubHive Document Delivery Service

The newly signed document delivery distribution agreement will make Springer Nature article acquisition available to life science companies that license access to PubHive’s scientific workflow management platform

QuBAS 3.0 cuts biostatistics method development time by 80%

Upgraded biostatistics software platform from Quantics offers enhanced flexibility for optimal early-stage development.

MedPharm collaborates with Mosanna to develop new drug to tackle Metabolic Obstructive Sleep Apnea

Cresset secures significant growth funding from SEP

Cresset, a drug discovery software scaleup, has raised growth capital from SEP to accelerate its product development and international expansion.

Nuvera PURE Reports name 2022 “best-in-class” pharmaceutical companies in oncology, neurology and immunology

Basepair™ - The Point and Click NGS Analysis & Visualization Platform Now Available in AWS Marketplace

Basepair™, The First Point and Click NGS Analysis & Visualization Platform of It's Kind is Now Available in AWS Marketplace

DISCOVERY LIFE SCIENCES INSTALLS THE LARGEST OLINK PLATFORM IN THE AMERICAS TO SUPPORT PROTEOMICS RESEARCH & BIOMARKER DEVELOPMENT AT SCALE

Discovery Life Sciences™ (Discovery), the Biospecimen and Biomarker Specialists™, has entered into an agreement with Olink Holding AB (publ) (Olink) and is installing the largest commercial platform of the Olink® technology in the Americas outside of Olink itself to become a leading global certified service provider for the Olink Proximity Extension Assay (PEA) technology, a unique anti-body based proteomic technology.

Curebase and Meru Health to Partner on Clinical Research for App-based Mental Health Treatment Program

Curebase, a company committed to democratizing access to clinical studies, today announced it is partnering with Meru Health on a three-year clinical trial to determine the effectiveness of the online mental healthcare provider’s 12-week treatment program for reducing depression among primary care patients.

VERICHEM OFFERS CLINICAL REFERENCE MATERIALS FOR THE CALIBRATION VERIFICATION TESTING OF LACTATE ASSAYS

VERICHEM LABORATORIES now offers a liquid stable and ready-to-use set of clinical reference materials for use with the clinical testing of Lactate.

Step up Research on Magnetic Metal Complexes Using Versatile Materials

High-Quality Dexmedetomidine Hydrochloride (API) Meeting CP & EP Standards

Liposomes as Drug Delivery Vehicles

BioIVT Launches GMP-grade VivoSTART Leukopaks for Cell and Gene Therapy Manufacturing

VivoSTART GMP-grade leukopaks complement BioIVT’s GMP-grade human AB serum, providing a complete solution for advanced therapy development.

Integrated DNA Technologies Expands Customization Options for Alt-R™ Custom CRISPR gRNA Libraries for Drug Discovery

Inizio Biotech makes key leadership appointment to meet demand from emerging biotech

Anti-inflammatory drug candidate DMXD-011 shows efficacy in ex-vivo human studies

TFDA Grants CTL Amedica License to Market MATISSE™ ACIF Cage System

The Taiwan Food and Drug Administration has granted CTL Amedica Corporation a license to market the MATISSE Anterior Cervical Interbody Fusion (ACIF) Cage System.